Cronos 集团 CRON
$3.61 −$0.11 (-2.96%)
休市 · Nov 6, 10:10 pm ET · 最新盘后价 $3.61 0.00%
开盘$3.70
昨收$3.72
当日区间$3.55 – $3.71
成交量1.32M
市值$1.32B
市盈率（TTM）22.6
股息率–
CRON 相关新闻
匹配 Cronos Group 或代码 CRON 的头条新闻，按最新排序。
- Analysts Offer Insights on Healthcare Companies: Community Health (CYH) and Cronos Group (CRON)
- TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.94 正面
- Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)
- Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Cronos Group (CRON) and Boston Scientific (BSX)
- Cronos Group Announces Extension of Shr Repurchase Program to the Toronto Stk Exchange CRON.T
- Citron Founder, a Short-Selling Giant, on Trial: CEO of Cronos Group (CRON.US) Cross-Examined, Unveiling Details of Alleged 'Short-and-Smear' Scheme
- Bernstein Initiates Cronos Group(CRON.US) With Hold Rating
- TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.02 正面
- Earnings Flash (CRON) Cronos Group Inc. Reports Q1 Revenue $45.2M, Vs. FactSet Est of $42.2M
- TD Cowen Initiates Cronos Group(CRON.US) With Buy Rating, Announces Target Price $3.28
- Cronos Completes Acquisition Of CanAdelaar, Europe's Largest Adult-Use Cannabis Company CRON.T
- CCORF Initiates Cronos Group(CRON.US) With Buy Rating, Announces Target Price $3.14
- Cronos Group (CRON) Gets a Hold From Bernstein
- Roth MKM Initiates Cronos Group(CRON.US) With Buy Rating
- BofA Securities Maintains Cronos Group(CRON.US) With Sell Rating, Cuts Target Price to $1.65 负面
暂无评论——快来第一个聊聊 CRON。